← News
Stocks· August 16, 2026 at 03:03 PM
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year
Authored by·Editorially reviewed
Onur Erkan YıldızFounder, Financial Engineer · CMB-licensed
Higher education in Financial Engineering and Money & Capital Markets. SPK (Turkey CMB) licence. 16 years across institutional markets, research, and quant-driven analytics.
NeutralMedium impact
AI summary
AbbVie has another blockbuster business emerging.
Affected symbols
AI commentary is generated from public news feeds and is not investment advice.
Related coverage
EarningsMedium impactNeutral1h
Sundar Pichai Raised Alphabet's Capex Guidance to $205 Billion the Same Quarter Google Cloud's Backlog Hit $514 Billion. Here's Which Number Actually Matters More.
via Yahoo Finance
NVDA
EarningsMedium impactNeutral1h
I Checked VIG's Top Holdings. They're Not What You'd Expect From a Dividend ETF.
via Yahoo Finance
NVDA
StocksMedium impactNeutral1h
Peter Thiel invests $118 million in surging big tech stock
via Yahoo Finance
AMZN
StocksMedium impactNeutral1h
Applied Materials Trades More Than 25% Below Its High With Revenue at a Record
via Yahoo Finance
NVDA